South Carolina workplace illnesses hit 25 year low in 1996
The South Carolina Labor and Licensing Department reports private industry injuries and illnesses fell to 5.9 per 100 workers in 1996 from 6.9 in 1994, with construction highest at 1.9 and finance, insurance and real estate lowest at 3.1. The survey covered almost 5,000 employers.
MENTIONED IN THIS ARTICLE
Columbia
State Labor and Licensing Department
Lewis F Gossett
South Carolina
Health data safeguards face conflicting needs and lax security
Security experts warn growing medical data use risks privacy as new federal rules aim to raise standards. They say doctors want fast access while patients demand privacy, and complex systems could hinder care in emergencies.
MENTIONED IN THIS ARTICLE
Baltimore
Security Administration
Dale Miller
Clinton
HMO
National Information Systems Security Conference
Miller
FDA approves Arthrotec arthritis drug with lower ulcer risk
Searle’s Arthrotec, a diclofenac sodium and misoprostol combination, wins FDA approval for rheumatoid and osteoarthritis. The NSAID lowers ulcer risk in high risk patients by coating and protecting the digestive tract while reducing acid and increasing mucus. Side effects include abdominal pain and diarrhea. use in pregnancy is not advised. The drug markets in February with undisclosed pricing.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
Searle
Arthrotec
FDA
Centers For Disease Control and Prevention
Revival of house calls promoted in New Jersey
A $1.1 million grant program from the University of Medicine and Dentistry of New Jersey-New Jersey Medical School aims to create model curricula to teach home care in medical schools. The effort, led by Dr. R. Knight Steel, targets more physicians visiting patients at home as aging populations and cost controls rise.
MENTIONED IN THIS ARTICLE
Trenton
N.J
University of Medicine and Dentistry of New Jersey-New Jersey Medical School
Newark
R. Knight Steel
Steel
New England Journal of Medicine
House
Inhaled antibiotic Tobi approved for cystic fibrosis
The FDA clears PathoGenesis Tobi Tobramycin for inhalation as the first inhaled antibiotic for CF. Six month trials show up to 12 percent lung function gain and 26 percent fewer hospitalizations. 3 percent report tinnitus while kidney and hearing risks remain monitored. PathoGenesis and CF Foundation note quality of life gains, with mid January prescription availability.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
PathoGenesis Corp
Michael Friedman
FDA
Robert J. Beall
Cystic
Tobi
Beall
Also Mentioned on This Page
S.C
Lindar. Johnson
Ennnated Press
Corinne Rieder
John A. Hartford
Lauran Neergaard
James M. Asbelle
D.M.D
Cults
Waterloo Stret
Sm Surety Lane
Aiken
Jon Carolina Podiatric
Bfe
Bel
Il Carolina Podiatric Medical Associates
Fone
Na Podiats Medical
Carolina Pediatric Medical
Tfeed
Cag
Dr. A
Ngela Fallon Zaremba
Greenwood
S. Zarembol
Exodus Doula Service
Center For Joint Replacement
Medical College of Georgia